Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy.

Purpose To examine the hypothesis that vascular-targeted photodynamic therapy (VTP) with WST11 and clinically relevant parameters can be used to ablate target tissues in a non-tumor-bearing large-animal model while selectively sparing blood vessels and collagen. Materials and Methods By using an institutional animal care and use committee-approved protocol, 68 ablations were performed in the kidneys (cortex and medulla) and livers of 27 adult pigs. Posttreatment evaluation was conducted with contrast material-enhanced computed tomography in the live animals at 24 hours. Immunohistochemistry was evaluated and histologic examination with hematoxylin-eosin staining was performed at 4 hours, 24 hours, and 7 days. Intravenous infusion of WST11 (4 mg per kilogram of body weight) was followed by using near-infrared illumination (753 nm for 20 minutes) through optical fibers prepositioned in target tissues by using a fixed template. Treated areas were scanned, measured, and statistically analyzed by using the Student t test and two-way analysis of variance. Results Focal WST11 VTP treatment in the liver and kidney by using a single optical fiber resulted in well-demarcated cylindrical zones of nonthermal necrosis concentrically oriented around the light-emitting diffuser, with no intervening viable parenchymal cells. The radius of ablated tissue increased from approximately 5 mm at 150 mW to approximately 7 mm at 415 mW (P < .01). Illumination through fiber triads at 1-cm separation resulted in confluent homogeneous necrosis. Patterns of acute injury within 24 hours were consistent with microcirculatory flow arrest and collagen preservation (demonstrated with trichrome staining). In the peripheral ablation zone, blood vessels at least 40 μm in diameter were selectively preserved and remained functional at 7 days. Ablated tissues exhibited progressive fibrosis and chronic inflammatory cell infiltrates. No histologic changes consistent with thermal injury were observed in blood vessels or collagen. The renal hilum and collecting system did not show treatment effect, despite treatment proximity. Conclusion WST11 VTP induces nonthermal tissue ablation in target tissue while preserving critical organ structures and bystander blood vessels within solid organs. (©) RSNA, 2016 Online supplemental material is available for this article.

[1]  E. Christensen Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion. , 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[2]  A. Scherz,et al.  Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model. , 2013, The Journal of urology.

[3]  Clare Allen,et al.  TOOKAD® Soluble vascular‐targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer , 2013, BJU international.

[4]  Brian Reid,et al.  Overdiagnosis and overtreatment in cancer: an opportunity for improvement. , 2013, JAMA.

[5]  M. Rousselet,et al.  Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer , 2013, Virchows Archiv.

[6]  P. Scardino,et al.  Targeted prostate cancer ablation: energy options , 2013, Current opinion in urology.

[7]  H. Wolfsen,et al.  Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma , 2013, Clinical endoscopy.

[8]  S. Crouzet,et al.  High‐intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer , 2012, BJU international.

[9]  K. Charpentier,et al.  Irreversible electroporation for the ablation of liver tumors: are we there yet? , 2012, Archives of surgery.

[10]  K. Odunsi,et al.  Photodynamic therapy effectively palliates gynecologic malignancies. , 2012, European Journal of Gynaecological Oncology.

[11]  Tinghe Yu,et al.  Adverse Events of Extracorporeal Ultrasound-Guided High Intensity Focused Ultrasound Therapy , 2011, PloS one.

[12]  A. Scherz,et al.  Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP) , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[13]  Christopher L Brace,et al.  Principles of and advances in percutaneous ablation. , 2011, Radiology.

[14]  James A Brink,et al.  Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. , 2010, Journal of the American College of Radiology : JACR.

[15]  Vyacheslav Kalchenko,et al.  Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad , 2010, PloS one.

[16]  Rafael V. Davalos,et al.  Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode , 2010, Breast Cancer Research and Treatment.

[17]  G. Gravante Thermal ablation for unresectable liver tumours, time to move forward? , 2010, World journal of gastrointestinal surgery.

[18]  A. Scherz,et al.  Prompt Assessment of WST11‐VTP Outcome Using Luciferase Transfected Tumors Enables Second Treatment and Increase in Overall Therapeutic Rate , 2008, Photochemistry and photobiology.

[19]  W. Lees,et al.  Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. , 2008, Journal of vascular and interventional radiology : JVIR.

[20]  Francisco Sanz-Rodríguez,et al.  Photodynamic therapy of cancer. Basic principles and applications , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[21]  Eliane Fuseau,et al.  Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling. , 2007, Journal of pharmaceutical sciences.

[22]  P. Humphrey,et al.  Precise characterization of renal parenchymal response to single and multiple cryoablation probes. , 2006, The Journal of urology.

[23]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 , 2005, Cell Death and Differentiation.

[24]  F. Lee,et al.  Radiofrequency versus microwave ablation in a hepatic porcine model. , 2005, Radiology.

[25]  A. Scherz,et al.  Novel Water-soluble Bacteriochlorophyll Derivatives for Vascular-targeted Photodynamic Therapy: Synthesis, Solubility, Phototoxicity and the Effect of Serum Proteins¶ , 2005 .

[26]  A. Belldegrun,et al.  Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. , 2005, Journal of endourology.

[27]  Avigdor Scherz,et al.  WST11, A Novel Water-soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular-targeted Photodynamic Activity Using Melanoma Tumors as a Model¶ , 2005, Photochemistry and photobiology.

[28]  Qian Peng,et al.  An outline of the hundred-year history of PDT. , 2003, Anticancer research.

[29]  D. Gervais,et al.  Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. , 2003, Radiology.

[30]  G. Gazelle,et al.  Tumor ablation with radio-frequency energy. , 2000, Radiology.

[31]  J Werner,et al.  Efficiency function: improvement of classical bioheat approach. , 1994, Journal of applied physiology.

[32]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[33]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[34]  J. Bai,et al.  High intensity focused ultrasound ablation of goat liver in vivo: Pathologic changes of portal vein and the "heat-sink" effect. , 2013, Ultrasonics.

[35]  K. Ha,et al.  New insights into the mechanisms for photodynamic therapy-induced cancer cell death. , 2012, International review of cell and molecular biology.

[36]  Steffen Jung,et al.  Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity , 2008, Cancer Immunology, Immunotherapy.

[37]  W. Zong,et al.  Necrotic death as a cell fate. , 2006, Genes & development.